New head-to-head data: BTK inhibitors in RR CLL patients with high-risk features
This video will be a a discussion between 2x leading Haematologists. The authors of the ELEVATE-RR, Professor John Seymour and Professor Stephan Stilgenbauer will review the study design as well as consider how the findings will make a difference to Australian clinical practice.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Professor John Seymour
Professor Stephan Stilgenbauer
Duration
1 H